KOUNTOUPES DENHAM CARR & REID, LLC

Lobbying for APOTEX, CORP. · Generic pharmaceutical manufacturer.

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 14, 2026

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

Florida

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Health Issues

Issues related to generic pharmaceuticals and drug shortages.

Tariff (miscellaneous tariff bills)

Issues related to tariffs and generic pharmaceuticals.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.